Koers SciClone Pharmaceuticals, Inc.

Aandelen

13-10-17	SciClone Pharmaceuticals : Consortium Led By GL Capital Completes Acquisition Of SciClone
29-08-17	Levi & Korsinsky, LLP Notifies Shareholders of SciClone Pharmaceuticals, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of October 30, 2017
16-08-17	SciClone Pharmaceuticals : Breakfast Technical Briefing on Drug Makers Stocks -- Depomed, Synergy Pharma, Novo Nordisk, and SciClone Pharma
10-08-17	SciClone Pharmaceuticals : Announces End Of Go-Shop Period With No Parties Designated As Excluded Parties
09-08-17	SciClone Pharmaceuticals : Reports Second Quarter 2017 Financial Results

Toevoegen aan een lijst 0 geselecteerde Om deze functie te gebruiken moet u een klant of lid zijn. Inloggen Registreren	Verschil (%)	Varia. 5d.	Varia. 1j.	Varia. 3j.	Kap.($)
SCICLONE PHARMACEUTICALS, INC.	-.--%	-.--%	-	-	0
ELI LILLY AND COMPANY	+0,11%	+1,71%	+63,52%	+117,61%	1.056 mld.
JOHNSON & JOHNSON	+0,27%	+0,92%	+51,33%	+73,35%	655 mld.
ABBVIE INC.	+0,73%	+0,68%	+20,70%	+74,90%	471 mld.
ROCHE HOLDING AG	-1,29%	-3,93%	+36,59%	+39,67%	342 mld.
NOVARTIS AG	-0,28%	+3,95%	+22,22%	+28,97%	277 mld.
ASTRAZENECA PLC	+0,12%	-1,19%	+12,93%	+12,78%	257 mld.
AMGEN INC.	+0,85%	+6,35%	+53,17%	+54,39%	226 mld.
GILEAD SCIENCES, INC.	+0,85%	+1,10%	+35,78%	+101,82%	189 mld.
NOVO NORDISK A/S	-0,13%	-2,72%	-28,38%	-60,90%	170 mld.
Gemiddelde	-0,21%	+0,97%	+29,76%	+49,18%	404,77 mld.
Gewogen gemiddelde per kap.	-0,22%	+1,04%	+40,19%	+69,61%

Werknemers

Sector